stock repurchase
OraSure Technologies Board Authorizes $40M Share Repurchase
The diagnostic test and sample management solutions developer intends to use cash on hand to fund the repurchase.
Becton Dickinson Board Authorizes Repurchase of up to 10M Shares
The firm said it has repurchased $750 million dollars of its stock to date in its fiscal 2025.
ProPhase Labs to Repurchase $6M of Common Stock
The company plans to repurchase up to $6 million of its common shares over a six-month period, which the company's board will periodically reevaluate.
CareDx to Repurchase up to $50M of Common Stock
The company plans to purchase common shares through open market, privately negotiated, or other means for up to 24 months.
Prenetics Authorizes $20M Share Buyback
The Hong Kong-based diagnostics and genetic testing firm will repurchase up to $20 million of its class A ordinary shares during a two-year period.
Nov 28, 2022
Standard BioTools Authorizes $20M Share Buyback
Aug 18, 2022
QuidelOrtho Board Authorizes $300M Share Repurchase
Jan 22, 2020
4basebio Announces Treasury Share Buyback
May 10, 2019
Bruker Authorizes $300M Share Repurchase Program
May 6, 2019
Qiagen Q1 Revenues Grow 2 Percent
Nov 28, 2017
Bio-Rad Authorizes $250M Share Repurchase Program
Jan 18, 2017
Qiagen Details $250M Synthetic Share Repurchase Plan
Nov 13, 2015
Thermo Fisher Announces $1B Share Repurchase Plan
Nov 13, 2015
Bruker Board OKs $225M Share Repurchase Program
Nov 2, 2015
Illumina Launches $250M Share Repurchase Program
May 28, 2015
Agilent Board Approves $1.14B Share Buyback Program
May 22, 2015
Bruker Authorizes Share Buyback Program
May 13, 2015
Qiagen Repurchasing up to $30M of Shares
Feb 24, 2015